Andreas Rummelt
Board Member
Healthcare
Xellia
Denmark
Biography
Andreas is a Partner and CEO of InterPharmaLink AG, Basle, Switzerland. His international career spans over twenty years in executive management positions at Novartis. Other Board positions: Member of the Board of Directors of Alexion Pharmaceuticals, USA, and Member of the Advisory Board of several privately held international companies Education: MSc and PhD in Pharmaceutical Sciences, University of Erlangen-Nuremberg, Germany.
Research Interest
Biotechnology